Mutational changes at HPRT gene locus in type-2 diabetes mellitus
DOI:
https://doi.org/10.31185/eduj.Vol2.Iss25.2735Keywords:
MutationalAbstract
Diabetes Mellitus (DM) is a metabolic defects of multiple etiologies characterized by disturbances of protein, fat and carbohydrate metabolism resulting from disorders in insulin secretion, insulin action or both. Studies of mutations at HPRT gene have provide insights into several aspects of somatic mutations in vivo, involving molecular mechanisms of mutagenesis, the relationship between DNA damage and mutation, as well as individual susceptibility factors like DNA repair capacity. In this study, somatic cell genetic marker; Hypoxanthine guanine phosphoribpsyltransferase (HPRT) was examined using short term lymphocyte culture in presence of 6-thioguanine (6-TG) as selective agent for HPRT on peripheral blood lymphocytes taken from twenty five type 2 DM patients using short term lymphocyte culture, their ages ranged between 30-80 years, and 15 healthy people with the same age range as control group.. Resistance to this selective agent refers to as genetic alterations at this HPRT locus. Lymphocytes taken from diabetic patients who were treated with 6-TG shows clear resistance to this analogue. Resistance to 6-TG in those diabetic patients is supported by high frequency of mutations fraction (MF) for those resistant cells. We conclude that type-2 diabetic patients have mutational changes at HPRT gene locus.Downloads
References
World Health Organization (1999).World Health Organization Consultation. Definition, Diagnosis and Classification of Diabetes Millitus and its Complications. Part I: Diagnosis and Classification of Diabetes Millitus. Report of WHO Cunsultation. Geneva.
Craig, M.E.; Hattersley, A.andDonaghue, K.C. (2009). Definition, epidemiology and classification of diabetes in children and adolescents. Pediatric Diabetes.10 (12): 3–12.
Concannon, P.; Gogolin-Ewens, K.J.; Hinds, D.A.; Wapelhorst, B.; Morrison, V.A.andStirling, B. (1998). A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet. 19: 292-306.
Davies, J.L.; Kawaguch,i Y.; Bennett, S.T.; Copeman, J.B.;Cordell, H.i.and Pritchard, L.E. (1994). Agenome-wide search for human type I diabetes susceptibility genes. Nature. 37:130-160.
Lillioja, S.and Wilton, A. (2009) .Agreement among type 2 diabetes linkage studies but a poor correlation with results from genome-wide association studies. Diabetologia 52: 1061–1074.
Majithia, A.R .and Florez, J.C. (2009). Clinical translation of genetic predictors for type 2 diabetes. Current Opinion in Endocrinology. Diabetes and Obesity .16:100-106.
De Mars, R. (1974). Resistance of cultured human fibroblasts and other cells to purine and pyrimidine analogues in relation to mutagenesis detection. Mutat. Res. 24: 335-364.
Falta ,M. T.; Atkinson ,M. A.; Allegretta ,M.; Vacek ,P. M .and Albertini ,R. J. (2000). Azathioprine associated T-cell mutations in insulin-dependent diabetes mellitus.Scand. J. Immunol. 51: 626-633.
Kelley, W. N.andWyngaardcn, J. B.; (1983). Clinical syndromes associated with hypoxanthine guanine phosphoribosyltransferase deficiency. In The Metabolic Basis of Inherited Disease: 20-32.
Hou, S.M.; Yang, K.; Nyberg, F.; Hemminik,K.;Pershagen, G.and Lambert, B.(1999). HPRT mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls. Carcinogenesis. 20: 437-444.
Vijayalaxmi.and Evans, H.J. (1984). Measurment of spontaneous and X-irradiation-induced 6-thioguanine-resistant human blood lymphocytes using a T-cell cloning technique. Mutat. Res. 125:87-94.
Shubber, E.K.; Al-Allak, B.M.and Nada, S.M. (1987). Spontaneous chromosomal aberrations and sister chromatid exchange in human lymphocytes, II, Effect of serum, incubation time and blood storage. Nucleus. 30:21-28.
Hinokio, Y.; Suzuki, S.; Hirai, M.; Chiba, M.; Hirai, A. and Toyota, T. (1999). Oxidative DNA damage in diabetes mellitus: Its association with diabetic complications.Diabetologia.42: 995–998
Ghali, Z.H. (2006).Cytogenetic, molecular, and tumor biomarker study from patients with prostate neoplasia. Ph.D. Thesis, College of Science, Baghdad University.Baghdad.Iraq.
Ahmed, E.H. (2006). Cytogenetic and molecularanalyses of breast cancer patients,. Ph.D. Thesis, College of Science, Baghdad University. Baghdad. Iraq.
Albertini, R.J.; Castle, K.L.andBorcherding, W.R (1982). T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. ProcNatlAcadSci USA.79:6617-6621.
Rice,S.C.; Vacek,P.; Homans,A.H.; Messier,T.; Rivers,J.; Kendall,H.E. and Finette,B.A. (2004) .Genotoxicity of therapeutic intervention in children with acute lymphoblastic leukemia. Cancer Res. 64:4464–4471.
Chu, E.H.Y.; and Mailing, H.V. (1968). Mammalian cell genetics, II. Chemical induction of specific locus mutations in Chinese hamster cells in vitro, Proc. Natl. Acad. Sci.61, 1306-1312.
Finette, B.A., Kendall, H., and Vacek, P.M. (2002): Mutational spectral analysis at the HPRT locus in healthy children. Mutat. Res., 505: 27-41.
Stout, J.T.andCaskey, C.T. (1985). HPRT: gene structure, expression, and mutation. Annu Rev Genet.19:127–148.
Everson, R.B.; Wehr, C.M.; Erexson, G.L.andMacGregor, J.T. (1988). Association of marginal folate depletion with increased human chromosomal damage in vivo: demonstration by analysis of micronucleated erythrocytes. J Natl Cancer Inst.80 (7):525-529.
Fenech, M. and Rinaldi, J. (1994). The relationship between micronuclei in human lymphocytes and plasma levels of vitamin C, vitamin E, vitamin B12, and folic acid. Carcinogenesis. 15: 1405-1411. [Abstract].
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Zafir Hassan Ghali, Noor Hussein Jamal
This work is licensed under a Creative Commons Attribution 4.0 International License.
